A day in the life of an antimicrobial pharmacist
In a busy London tertiary hospital I start my day by replying to any urgent emails relating to antimicrobials (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 7, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Infectious Disease Patient care antimicrobial audit Blogs resistance Stewardship Usage Source Type: news
A new study has found that there are five kinds of prostate cancer
News reports that scientists from the Cancer Research UK Cambridge Institute and Addenbrooke’s Hospital have discovered that there are five kinds of prostate cancer (Source: Pharmacy Europe)
Source: Pharmacy Europe - July 31, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Oncology Patient care biopsy blood test CRUK Latest News minimally invasive treatment prostate cancer psa surveillance Source Type: news
A day in the life of a mental health pharmacist
Importantly, each patient is treated as an individual and decisions about their medication are always patient-centred. (Source: Pharmacy Europe)
Source: Pharmacy Europe - July 24, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: Home care Psychiatry advice Blogs Experience mental health Patient Centred Teamwork Source Type: news
NICE recommends secukinumab with three-month window for NHS implementation
Secukinumab is an innovative new treatment licensed for use in adults with moderate-to-severe plaque psoriasis (Source: Pharmacy Europe)
Source: Pharmacy Europe - July 22, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Industry News Dermatology Patient care Cosentyx Latest News nice plaque psoriasis secukinumab Source Type: news
New generation topical pain relief from Futura Medical
Futura Medical has developed a "new generation” of topical pain relief with two products that target more active ingredients directly to the point of pain (Source: Pharmacy Europe)
Source: Pharmacy Europe - July 14, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Industry News Generic medicines Pain management Patient care Latest News oral pain killers osteoarthritis pain relief topical Source Type: news
New therapy option for CAP and HAP
Zevtera® (Ceftobiprole medocaril): the latest generation Cephalosporin with broad-spectrum of activity launches in the UK (Source: Pharmacy Europe)
Source: Pharmacy Europe - July 9, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Industry News Drug development Therapeutic drug monitoring Drug discovery Infectious Disease Patient care AMR antimicrobial resistance broad-spectrum antibiotics cap Cephal Source Type: news
NHS England approves routine commissioning for Parkinson’s treatment Duodopa®
Duodopa® (Levodopa-carbidopa intestinal gel) recommended through NHSE’s specialised commissioning prioritisation process (Source: Pharmacy Europe)
Source: Pharmacy Europe - July 3, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Industry News Legislation & regulation Neurology Patient care Policy practice commissioning policy dopamine duodopa IFR Latest News LCIG levodopa Levodopa-carbidopa intestinal gel Source Type: news
Napp receives approval from MHRA to prescribe Targinact® for the treatment of RLS
Napp Pharmaceuticals Limited has announced that Targinact, a fixed combination of prolonged-release oxycodone/naloxone, has received approval for use in the UK. This follows the European Commission's positive decision in January 2015 to recommend Targinact as a second line symptomatic treatment for patients with severe to very severe idiopathic restless legs syndrome (RLS), after failure of dopaminergic therapy. (1,2) (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 29, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Industry News Neurology dopaminergic therapy idiopathic restless leg syndrome Latest News oxycodone/naloxone targinact Source Type: news
Type II diabetes: Synjardy® approved in the EU
Synjardy® has been granted marketing authorisation by the European Commission for the treatment of adults with type II diabetes (T2D) in the European Union (EU). Synjardy® is a new single-pill combination therapy from the Boehringer Ingelheim and Eli Lilly and Company diabetes alliance. (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 29, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Diabetes blood glucose-lowering drugs empagliflozin glycaemic control Jardiance Latest News metformin odium glucose cotransporter 2 SGLT2 synjardy T2D Source Type: news
Reducing iodine levels in coronary angiography
Latest data from multicentre trials support the thesis that using lower iodine concentration achieves adequate results in terms of image quality in coronary computed tomography investigations (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 28, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Cardiovascular medicine Featured Articles Source Type: news
Reducing exacerbations in COPD
Strategies by which pharmacists can support patients in minimising the risk of exacerbations in chronic obstructive pulmonary disease, and ways to optimise self-management and overall control of this condition are discussed (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 28, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Respiratory Featured Articles Source Type: news
Type 2 diabetes patients with metformin intolerance
This article briefly reviews the strategies used to effectively treat type 2 diabetes patients that are unable to tolerate metformin (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 28, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Diabetes Featured Articles Source Type: news
Gastrointestinal conditions and their treatment in oncology
Cancer and its treatments may cause mucositis, nausea, vomiting, diarrhoea and constipation. Pharmacological treatments and dietary recommendations can prevent and treat these disorders (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 28, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Oncology Featured Articles Source Type: news
Diagnosis and management of acute heart failure
This article focuses on the treatment options for the management of this patient group (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 28, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Cardiovascular medicine Featured Articles Source Type: news
Regeneron and Sanofi announce positive top line results from Phase III studies with sarilumab
Regeneron Pharmaceuticals, Inc. and Sanofi announced that a Phase III study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo. (Source: Pharmacy Europe)
Source: Pharmacy Europe - May 21, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Industry News Drug development Rheumatology Patient care DMARD HAQ-DI human IL-6 receptor antibody Latest News rheumatoid arthritis sarilumab TNF-IR Source Type: news
